Department of Bacteriology, The School of Medicine, University of Pennsylvania, Philadelphia.
J Gen Physiol. 1942 Jul 20;25(6):805-17. doi: 10.1085/jgp.25.6.805.
The inhibiting effects of sulfonamide drugs and their derivatives on the anaerobic decarboxylation of pyruvic acid by Staphylococcus aureus, Escherichia coli, baker's and brewer's yeast, and a carboxylase preparation from brewer's yeast have been investigated. These drugs are: sulfanilamide, sulfapyridine, sulfadiazine, sulfamethyldiazine, sulfathiazole, sulfamethylthiazole, sulfanilamido-5-ethyl-4-thiazolone, 2-aminopyrimidine, 2-aminothiazole, and 2-aminopyridine. The sulfathiazole ring appears to exercise decidedly greater specific inhibiting effect on the carboxylases of Staph. aureus and E. coli. The inhibiting effect on yeast carboxylase is non-differentiable among all the substances tried, except sulfamethyldiazine which is completely ineffective on the carboxylases of the organisms studied. The specific inhibitory effect of sulfathiazole on the carboxylases of Staph. aureus and E. coli in comparison to sulfanilamide, sulfapyridine, and sulfadiazine is in harmony with in vivo and in vitro experimental results of other investigators. The results of the present investigation appear to support the hypothesis (1) that sulfonamides exert their bacteriostatic action through chemical affinity for the carrier proteins of certain respiratory enzymes of the bacterial cell, and that this affinity may in part be related to structural similarity between components of the drugs and the corresponding respiratory coenzymes.
研究了磺胺类药物及其衍生物对金黄色葡萄球菌、大肠杆菌、面包酵母和啤酒酵母的丙酮酸厌氧脱羧作用以及从啤酒酵母中提取的羧化酶的抑制作用。这些药物是:磺胺、磺胺吡啶、磺胺嘧啶、磺胺甲基嘧啶、磺胺噻唑、磺胺甲基噻唑、磺胺甲噻唑、5-乙基-4-噻唑酮、2-氨基嘧啶、2-氨基噻唑和 2-氨基吡啶。磺胺噻唑环对金黄色葡萄球菌和大肠杆菌的羧化酶表现出明显更强的特定抑制作用。除磺胺甲基嘧啶对所研究的生物体的羧化酶完全无效外,所有尝试的物质对酵母羧化酶的抑制作用都没有区别。磺胺噻唑对金黄色葡萄球菌和大肠杆菌羧化酶的特异性抑制作用与其他研究人员的体内和体外实验结果一致。本研究的结果似乎支持了以下假设:磺胺类药物通过与细菌细胞某些呼吸酶的载体蛋白的化学亲和力发挥其抑菌作用,这种亲和力可能部分与药物成分和相应呼吸辅酶之间的结构相似性有关。